The future of pharma

Phio’s eHealth platform enables pharma professionals to deliver value and outcome-based healthcare by enhancing the MSK care continuum through innovative digital pathways.

/01

Increased access

By streamlining the triage process and offering tools that patients can use at home, Phio Access helps more patients access the care they need.

/02

Competitive advantage

Phio Access is an industry leader in the new era of MSK healthcare tech. By becoming an early adopter of digtal-first triage, pharmaceutical companies can offer a superior patient experience with easy-to-use eHealth tools that set them ahead of their competition.

Phio Engage takes the same approach to care management with accessible and responsive user interface (UI) that patients want to use and providers find useful.

/03

Actionable insights

Phio Access and Phio Engage provide pharmaceutical companies with insights into the complete patient journey, from the triage process to care, from pre-op to recovery. Valuable closed-loop health outcomes data on a large range of conditions, including those involving pharmaceuticals and devices, allowing for more optimised care.

/04

Improved compliance

Phio Engage provides an easy-to-use, readily accessible solution to at-home care that supports patients to play an engaged and active role in their recovery process, encouraging compliance for a faster recovery and improved health outcome.

How we help pharma

From triage to recovery, Phio gives pharmaceutical companies superior patient access, compliance and data.

Here’s how:

Let’s talk

Questions? Suggestions?
We want to hear from you and we’re ready to help

Simply fill out the form below and we’ll get you started on your journey to better health.

Thank you.
Your enquiry has been received.
Oops! Something went wrong while submitting the form.

Be part of the future of healthcare

When it comes to healthcare, we never stand still. Sign up to be the first to know about what we’re working on, how we can help you and the latest from our blog.